» Articles » PMID: 27025239

Acute Heart Failure with Cardiomyocyte Atrophy Induced in Adult Mice by Ablation of Cardiac Myosin Light Chain Kinase

Abstract

Aims: Under pressure overload, initial adaptive hypertrophy of the heart is followed by cardiomyocyte elongation, reduced contractile force, and failure. The mechanisms governing the transition to failure are not fully understood. Pressure overload reduced cardiac myosin light chain kinase (cMLCK) by ∼80% within 1 week and persists. Knockdown of cMLCK in cardiomyocytes resulted in reduced cardiac contractility and sarcomere disorganization. Thus, we hypothesized that acute reduction of cMLCK may be causative for reduced contractility and cardiomyocyte remodelling during the transition from compensated to decompensated cardiac hypertrophy.

Methods And Results: To mimic acute cMLCK reduction in adult hearts, the floxed-Mylk3 gene that encodes cMLCK was inducibly ablated in Mylk3(flox/flox)/merCremer mice (Mylk3-KO), and compared with two control mice (Mylk3(flox/flox) and Mylk3(+/+)/merCremer) following tamoxifen injection (50 mg/kg/day, 2 consecutive days). In Mylk3-KO mice, reduction of cMLCK protein was evident by 4 days, with a decline to below the level of detection by 6 days. By 7 days, these mice exhibited heart failure, with reduction of fractional shortening compared with those in two control groups (19.8 vs. 28.0% and 27.7%). Severely convoluted cardiomyocytes with sarcomeric disorganization, wavy fibres, and cell death were demonstrated in Mylk3-KO mice. The cardiomyocytes were also unable to thicken adaptively to pressure overload.

Conclusion: Our results, using a new mouse model mimicking an acute reduction of cMLCK, suggest that cMLCK plays a pivotal role in the transition from compensated to decompensated hypertrophy via sarcomeric disorganization.

Citing Articles

Novel cardiac myosin inhibitor for hypertrophic cardiomyopathy.

Szczesna-Cordary D J Gen Physiol. 2024; 156(10).

PMID: 39136654 PMC: 11318667. DOI: 10.1085/jgp.202413640.


Loss of cardiac myosin light chain kinase contributes to contractile dysfunction in right ventricular pressure overload.

Prasad V, Makkaoui N, Rajan R, Patel A, Mainali B, Bagchi P Physiol Rep. 2022; 10(7):e15238.

PMID: 35384363 PMC: 8981447. DOI: 10.14814/phy2.15238.


Myosin Light Chain Kinase Modulates to Improve Myocardial Hypoxia/Reoxygenation Injury.

Zhang Q, Liu X, Yi W, Zhang C J Healthc Eng. 2022; 2022:8124343.

PMID: 35378949 PMC: 8976627. DOI: 10.1155/2022/8124343.


Proteomics study on the effect of silybin on cardiomyopathy in obese mice.

Wang F, Li Z, Song T, Jia Y, Qi L, Ren L Sci Rep. 2021; 11(1):7136.

PMID: 33785854 PMC: 8009917. DOI: 10.1038/s41598-021-86717-x.


Aging Attenuates Cardiac Contractility and Affects Therapeutic Consequences for Myocardial Infarction.

Dong M, Yang Z, Fang H, Xiang J, Xu C, Zhou Y Aging Dis. 2020; 11(2):365-376.

PMID: 32257547 PMC: 7069457. DOI: 10.14336/AD.2019.0522.


References
1.
Koitabashi N, Bedja D, Zaiman A, Pinto Y, Zhang M, Gabrielson K . Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models. Circ Res. 2009; 105(1):12-5. PMC: 2747596. DOI: 10.1161/CIRCRESAHA.109.198416. View

2.
Velden J, Papp Z, Boontje N, Zaremba R, de Jong J, Janssen P . The effect of myosin light chain 2 dephosphorylation on Ca2+ -sensitivity of force is enhanced in failing human hearts. Cardiovasc Res. 2003; 57(2):505-14. DOI: 10.1016/s0008-6363(02)00662-4. View

3.
Warren S, Briggs L, Zeng H, Chuang J, Chang E, Terada R . Myosin light chain phosphorylation is critical for adaptation to cardiac stress. Circulation. 2012; 126(22):2575-88. PMC: 3510779. DOI: 10.1161/CIRCULATIONAHA.112.116202. View

4.
Houser S, Piacentino 3rd V, Weisser J . Abnormalities of calcium cycling in the hypertrophied and failing heart. J Mol Cell Cardiol. 2000; 32(9):1595-607. DOI: 10.1006/jmcc.2000.1206. View

5.
Soderling T, Stull J . Structure and regulation of calcium/calmodulin-dependent protein kinases. Chem Rev. 2001; 101(8):2341-52. DOI: 10.1021/cr0002386. View